Latest Intelligence

The following industries match your search criteria:

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Click here to sort results by relevance. Click on heading titles to sort results by different field.

Type Product title / description Pub Price
Expert View
Expert View

Fungal Infections: Maximizing potential in a saturated market

Superficial fungal infections are found on the peripheral surfaces of the body such as the skin, hair and nails. In spite of posing no threat of mortality, these infections are very common and represent an attractive potential market. However, low presentation rates and frequent misdiagnosis mean that only a small proportion of this patient potential is currently being realized. <BR />

Published By Datamonitor
06 Jun 2003
CommentWire
CommentWire

Britvic: tweenagers prove elusive

Britvic's recently launched Freekee Soda soft drink faces a make or break summer period. With faltering sales three months into launch, Britvic is realizing the difficulties of appealing to young consumers. Despite their growing purchasing power, tweenagers are a difficult consumer group to crack.

Published By Datamonitor
01 Jul 2003
Expert View
Expert View

Novel treatment paradigms in asthma and COPD

Asthma and chronic obstructive pulmonary disease (COPD) are chronic lung disorders affecting over 80 million people in the seven major drug markets. The prevalence of asthma has risen dramatically over the last 30 years, and due to tobacco consumption in the 1970s and 1980s, COPD has also become a major problem, costing the US health system over $30 billion in medical costs in 2000.

Published By Datamonitor
14 Jul 2003
CommentWire
CommentWire

Wrigley: the innovation game

Wrigley's new oral health gum offering shows it understands well the need to stay at the cutting edge of product innovation. With a consumer base hungry for these products, Wrigley must use its brand strength to fight off competitors that are keen for a share of this lucrative market.<BR />

Published By Datamonitor
08 Aug 2003
Expert View
Expert View

Food Allergies: Drug makers set to capitalize?

Although food allergies have been recognized in the medical community since the beginning of the century, they have recently been receiving much more public attention due to the perceived increasing prevalence of the condition in the US, Europe and Japan. As new research and treatments emerge, the potential for increased profits in this under-treated area will increase dramatically.

Published By Datamonitor
12 Sep 2003
Expert View
Expert View

Oral Mucositis: Amgen's Palifermin a potential treatment

Oral mucositis is a common and debilitating side effect of cancer therapies that threatens the successful treatment of 600,000 people worldwide. Inexpensive treatments can sometimes alleviate mucositis, but a truly effective treatment has yet to be launched. With Palifermin already in phase III trials, Amgen is already planning on filling this void. This outcome however, is less than certain.

Published By Datamonitor
19 Sep 2003
Expert View
Expert View

Advair: GlaxoSmithKline to lead the asthma market

New research from Datamonitor has suggested that the asthma/COPD market will enjoy a 35% increase and reach a value of over $18 billion by 2011. This growth will be largely driven by the success of drug delivery technology, rather than novel drug launches. GlaxoSmithKline should therefore be the main beneficiary of this market expansion although its rivals are looking to close the gap.

Published By Datamonitor
24 Oct 2003
Expert View
Expert View

Health craze will continue to drive food and drink industries

By 2009, the low carb trend will be but a distant memory for the food industry and consumers alike. Cholesterol-reducing products, meanwhile, are set for a boom in growth. These are the conclusions of a survey of 1,250 food and drinks industry executives from around the globe, conducted by Reuters Business Insight...

Published By Datamonitor
02 Nov 2004
Expert View
Expert View

Britons splash the cash to be cool

A new study from Datamonitor has revealed that Britons are willing to pay a premium to be 'cool'. Image conscious consumers are increasingly seeking brands that support their lifestyles- with alcoholic drinks, fragrances and make-up the products most likely to have an impact on the 'cool' consumer.

Published By Datamonitor
21 Feb 2005
CommentWire
CommentWire

Cadbury-Schweppes: fighting fire with fizz

Cadbury-Schweppes' restructuring plan has generated funds for investment in marketing, research and development. The company's success in the US diet carbonated beverages markets has given it the impetus for greater focus on this segment. However, its reliance for success on an ailing brand such as 7-UP may prove a hindrance in this approach.

Published By Datamonitor
24 Feb 2005

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.